KLK3 and prostate carcinoma: Well-known prostate cancer signatures, including KLK3, a serine protease used as a serum marker in prostate cancer screening and disease monitoring, and PRAC, a highly expressed gene in prostate cancer (Edwards et al., 2005), have been selected by 7 and 3 studies, respectively.